Document Detail


Cardioprotection: chances and challenges of its translation to the clinic.
MedLine Citation:
PMID:  23095318     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Myocardial infarct size is a major determinant of prognosis. Ischaemic preconditioning with brief coronary occlusion and reperfusion before a sustained period of coronary occlusion with reperfusion delays infarct development. Ischaemic postconditioning uses repetitive brief coronary occlusion during early reperfusion of myocardial infarction and reduces infarct size. Remote ischaemic preconditioning uses brief ischaemia and reperfusion of a distant organ to protect the myocardium. These conditioning protocols recruit a complex signal cascade of sarcolemmal receptor activation, intracellular enzyme activation, and ultimately mitochondrial stabilisation and inhibition of death signalling. Conditioning protocols have been successfully used in patients undergoing elective coronary revascularisation and reperfusion after acute myocardial infarction. Pharmacological recruitment of cardioprotective signalling has also been used to reduce infarct size, but so far without prognostic benefit. Outcomes of cardioprotection are affected by age, sex, comorbidities, and drugs, but also by technical issues related to determination of infarct size and revascularisation procedure.
Authors:
Gerd Heusch
Related Documents :
20926788 - Impaired atp kinetics in failing in vivo mouse heart.
9059538 - Thrombolysis-induced coronary reperfusion causes acute and massive interstitial release...
21289918 - Drug-eluting stents vs. coronary artery bypass-grafting in coronary heart disease.
7775548 - Perioperative infusion of nifedipine and metoprolol provides antiischemic and antiarrhy...
3405018 - Quantitation of myocardial dyssynergy in closed-chest dogs by two-dimensional echocardi...
8528488 - Reperfusion arrhythmias: role of early afterdepolarizations studied by monophasic actio...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-10-19
Journal Detail:
Title:  Lancet     Volume:  -     ISSN:  1474-547X     ISO Abbreviation:  Lancet     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-25     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  2985213R     Medline TA:  Lancet     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 Elsevier Ltd. All rights reserved.
Affiliation:
Institut für Pathophysiologie, Universitätsklinikum Essen, Essen, Germany. Electronic address: gerd.heusch@uk-essen.de.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Anisakis simplex Hypersensitivity Is Associated with Chronic Urticaria in Endemic Areas.
Next Document:  The nature of progress in nanopatterning.